NPPB and heart failure: Even though the measurement of NT-proBNP is still debated in the case of patients with DOX-induced cardiotoxicity, it remains an important, highly used marker for heart failure even in clinical trials as its increase is related to early cardiac injury (Advani et al. 2017; Mladosievicova et al. 2012; Rüger et al. 2020).